DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Director Gregory T. Lucier Acquires 3,577 Shares

DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Free Report) Director Gregory T. Lucier purchased 3,577 shares of DENTSPLY SIRONA stock in a transaction on Friday, May 31st. The shares were acquired at an average cost of $27.95 per share, for a total transaction of $99,977.15. Following the purchase, the director now owns 58,374 shares in the company, valued at $1,631,553.30. The acquisition was disclosed in a document filed with the SEC, which is available through this link.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $28.04 on Tuesday. The firm’s fifty day simple moving average is $29.97 and its 200 day simple moving average is $32.45. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA Inc. has a twelve month low of $26.27 and a twelve month high of $41.65. The firm has a market capitalization of $5.82 billion, a price-to-earnings ratio of -63.73, a PEG ratio of 1.25 and a beta of 1.04.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting analysts’ consensus estimates of $0.42. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The company had revenue of $953.00 million for the quarter, compared to analysts’ expectations of $969.45 million. During the same quarter in the previous year, the firm posted $0.39 earnings per share. The firm’s quarterly revenue was down 2.6% on a year-over-year basis. As a group, equities research analysts expect that DENTSPLY SIRONA Inc. will post 2.03 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Shareholders of record on Friday, June 28th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 2.28%. The ex-dividend date is Friday, June 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -145.45%.

Institutional Trading of DENTSPLY SIRONA

A number of hedge funds have recently made changes to their positions in XRAY. VisionPoint Advisory Group LLC grew its holdings in DENTSPLY SIRONA by 104.2% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 395 shares in the last quarter. Principal Securities Inc. acquired a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at about $26,000. Headlands Technologies LLC purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth about $30,000. Parkside Financial Bank & Trust lifted its stake in shares of DENTSPLY SIRONA by 33.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after acquiring an additional 292 shares in the last quarter. Finally, Anchor Investment Management LLC purchased a new position in DENTSPLY SIRONA in the fourth quarter valued at about $47,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

XRAY has been the subject of several analyst reports. Evercore ISI dropped their target price on DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating for the company in a research note on Friday, May 3rd. Leerink Partnrs reiterated an “outperform” rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. Needham & Company LLC cut their price target on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a research note on Friday, May 3rd. Finally, Robert W. Baird lowered their price objective on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a research note on Friday, May 3rd. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $35.22.

Check Out Our Latest Research Report on XRAY

DENTSPLY SIRONA Company Profile

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Recommended Stories

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.